Chiba, Japan

Rikako Taira

This inventor holds 6 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Novozymes A/s, Novo Zymes North America, Inc. Active years: 2002-2017.

USPTO Granted Patents = 6 

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Tokyo, JP (2011 - 2012)
  • Chiba, JP (2002 - 2017)

Company Filing History:


Years Active: 2002-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Rikako Taira: Innovator in Polynucleotide Technology

Introduction

Rikako Taira is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of biotechnology, particularly in the area of polynucleotides. With a total of 6 patents to her name, Taira's work has advanced the understanding and application of genetic materials.

Latest Patents

One of Taira's latest patents focuses on isolated polynucleotides having leader sequence function. This invention relates to nucleic acid constructs, vectors, and host cells that incorporate these polynucleotides. Additionally, the methods developed using these polynucleotides aim to enhance the production of polypeptides, showcasing her innovative approach to genetic engineering.

Career Highlights

Throughout her career, Rikako Taira has worked with notable companies such as Novozymes A/S and Novo Zymes North America, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Taira has had the opportunity to work alongside talented individuals, including Hiroaki Udagawa and Shinobu Takagi. These collaborations have further enriched her research and development efforts in biotechnology.

Conclusion

Rikako Taira's contributions to the field of polynucleotide technology highlight her role as an influential inventor. Her innovative patents and collaborations continue to shape advancements in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…